Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)

Clinical trial NCT07600749 · RECRUITING

Trial details

NCT number: NCT07600749
Sponsor: Merck Sharp & Dohme LLC
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Neoplasm

Start date: 2026-06-18
Primary completion: 2029-10-04
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.